Welcome to Public Health On Call, a podcast from the Johns Hopkins Bloomberg School of Public Health,

where we bring evidence, experience, and perspective to make sense of today's leading health challenges.

If you have questions or ideas for us, please send an email to public health question at jh.h.edu.

That's public health question at jh.u.edu for future podcast episodes.

This is Lindsay Smith-Rogers, producer of Public Health On Call.

Today, we kick off our election series series where we look at what's at stake

for public health with the 2024 presidential election. In today's episode, we explore

global public health and the potential implications of each administration when it comes to the

U.S.'s involvement with institutions like the WHO, funding of initiatives like PEPFAR, and how approaches

to domestic health can have tremendous impact on global health. My guest is Thomas Boyke,

an expert in health policy law and the inaugural Bloomberg chair in global health at the Council

on Foreign Relations. Let's listen.

Thomas Boyke, thank you so much for joining us on public health on call. Let's start off.

Can you tell us a little bit about your work with the Council on Foreign Relations?

Sure. I direct the Global Health Program at the Council on Foreign Relations.

The council itself is a membership organization. It's a publisher of Foreign Affairs Magazine, but it's a think tank. It's a policy research institute. So we spend

a lot of our time doing policy relevant, rigorous research to try to explore the intersection and advance the use of U.S. foreign policy and national

security to improve global health and the safety of Americans.

Well, then you are absolutely the right person to have this conversation with. We are coming up on the U.S. presidential election.

We're looking at global public health,

and there are implications and proposed key efforts of each administration.

Let's start off by talking about some of the direct implications

...